We are live on ! Find out more
Royal Bank of Canada

Royal Bank of Canada Portfolio holdings

AUM $570B
1-Year Est. Return 27.57%
 

Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.

This Fund
S&P 500
This Quarter Est. Return
+4.82%
1 Year Est. Return
+27.57%
3 Year Est. Return
+75.99%
5 Year Est. Return
+94.97%
10 Year Est. Return
+325.25%
AUM
$228B
AUM Growth
+$19.5B
Cap. Flow
+$9.66B
Cap. Flow %
4.24%
Top 10 Hldgs %
19.68%
Holding
7,447
New
331
Increased
2,461
Reduced
3,156
Closed
486

Sector Composition

Rank Sector Weight
1 Financials 21.58%
2 Energy 8.65%
3 Industrials 8.54%
4 Technology 7.61%
5 Communication Services 7.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EPM icon
6501
Evolution Petroleum
EPM
$135M
$0 ﹤0.01%
21
-2,274
-99% -$16K
EQBK icon
6502
Equity Bancshares
EQBK
$1.06B
$0 ﹤0.01%
14
-924
-99% -$32.1K
EQT icon
6503
CALL
EQT Corp
EQT
$33.6B
-221,359
Closed -$7.86M
ESI icon
6504
CALL
Element Solutions
ESI
$9.53B
-115,000
Closed -$1.28M
EVGN icon
6505
Evogene
EVGN
$10.6M
-100
Closed -$4K
FAST icon
6506
CALL
Fastenal
FAST
$59B
-200,000
Closed -$2.28M
FATE icon
6507
Fate Therapeutics
FATE
$315M
$0 ﹤0.01%
70
-3,355
-98% -$15K
FBIO icon
6508
Fortress Biotech
FBIO
$96M
$0 ﹤0.01%
2
-193
-99% -$11.4K
FC icon
6509
Franklin Covey
FC
$226M
$0 ﹤0.01%
21
-825
-98% -$16.2K
FCAP icon
6510
First Capital
FCAP
$219M
$0 ﹤0.01%
1
FCBC icon
6511
First Community Bankshares
FCBC
$936M
-1,525
Closed -$44K
FCCO icon
6512
First Community Corp
FCCO
$324M
-622
Closed -$13K
FDMO icon
6513
Fidelity Momentum Factor ETF
FDMO
$943M
-17
Closed
FEIM icon
6514
Frequency Electronics
FEIM
$862M
$0 ﹤0.01%
7
FGBI icon
6515
First Guaranty Bancshares
FGBI
$138M
$0 ﹤0.01%
1
-360
-100% -$7.41K
FGNX
6516
FG Nexus Inc
FGNX
$41.6M
0
FISI icon
6517
Financial Institutions
FISI
$827M
-1,335
Closed -$38K
FIVE icon
6518
CALL
Five Below
FIVE
$13.4B
-30,000
Closed -$1.65M
FL
6519
PUT
DELISTED
Foot Locker
FL
-36,000
Closed -$1.27M
FLNT
6520
Fluent
FLNT
$130M
$0 ﹤0.01%
3
-244
-99% -$6.5K
FMAO icon
6521
Farmers & Merchants Bancorp
FMAO
$490M
$0 ﹤0.01%
6
-703
-99% -$27.6K
FMNB icon
6522
Farmers National Banc Corp
FMNB
$968M
-2,289
Closed -$34K
FNKO icon
6523
Funko
FNKO
$338M
$0 ﹤0.01%
+63
New +$486
FWDI
6524
Forward Industries Inc
FWDI
$303M
$0 ﹤0.01%
1
FRBA icon
6525
First Bank
FRBA
$470M
-2
Closed

Similar funds

Royal Bank of Canada's Q4 2017 Portfolio in Review

As of Q4 2017, Royal Bank of Canada held 7,447 positions worth $228B, up 9.4% from $208B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Royal Bank of Canada deployed $9.66B of net new capital in Q4 2017, opening 331 new positions and adding to 2,461 existing holdings. Its largest new stake was Maxar Technologies Inc. Common Stock: 2,562,561 shares worth $165M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 22% a quarter earlier, followed by Energy and Industrials.

On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $611M trimmed.

  • Royal Bank of Canada's largest Q4 2017 buy was Maxar Technologies Inc. Common Stock: 2,562,561 shares worth $165M.
  • Royal Bank of Canada added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $2.31B increase.
  • Royal Bank of Canada's biggest Q4 2017 reduction was iShares Core S&P 500 ETF, cutting an estimated $611M.
  • Royal Bank of Canada fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $144M.
  • Royal Bank of Canada's ten largest holdings make up 20% of its $228B portfolio in Q4 2017.
  • Royal Bank of Canada opened 331 new positions and closed 486 in Q4 2017.
  • Royal Bank of Canada's portfolio value rose 9.4% quarter-over-quarter to $228B.

Based on Royal Bank of Canada's 13F filing for Q4 2017, filed 14 Feb 2018.